A cross-sectional study to evaluate the effectiveness of XALKORI Therapeutic Management Guide among physician prescribing XALKORI in Europe

First published 02/09/2014

Last updated 02/07/2024

EU PAS number:

EUPAS7389

Study

Finalised

Documents

Study protocol

Initial protocol

A8081049_PROTOCOL_Crizotinib Physician Survey_25March2014

English (958.16 KB - PDF) View document

Updated protocol

A8081049_PROTOCOL AMENDMENT 2_Crizotinib Physician Survey_30 March 2015 Clean_register

First published: 22/02/2024

English (346.74 KB - PDF) View document

Study results

Crizotinib A8081049 NI Study Report

English (6.54 MB - PDF) View document

Study report

Other information

Secondary tabs